A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

NCT04053881 · clinicaltrials.gov ↗
COMPLETED
Status
412
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Biopharma SRL